<VariationArchive VariationID="498909" VariationName="NM_004369.4(COL6A3):c.6310-28_6325del" VariationType="Deletion" Accession="VCV000498909" Version="10" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="490333" VariationID="498909">
      <GeneList>
        <Gene Symbol="COL6A3" FullName="collagen type VI alpha 3 chain" GeneID="1293" HGNC_ID="HGNC:2213" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q37.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="237324018" stop="237414164" display_start="237324018" display_stop="237414164" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="238232654" stop="238322849" display_start="238232654" display_stop="238322849" Strand="-" />
          </Location>
          <OMIM>120250</OMIM>
        </Gene>
        <Gene Symbol="LOC122889011" FullName="Sharpr-MPRA regulatory region 1020" GeneID="122889011" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q37.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="237359226" stop="237359520" display_start="237359226" display_stop="237359520" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_004369.4(COL6A3):c.6310-28_6325del</Name>
      <CanonicalSPDI>NC_000002.12:237359234:TTTCTCCTACTTCGCCCTAAGAGGGAATAAGGCGGACAGGTAAGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q37.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="237359235" stop="237359278" display_start="237359235" display_stop="237359278" variantLength="44" positionVCF="237359234" referenceAlleleVCF="ATTTCTCCTACTTCGCCCTAAGAGGGAATAAGGCGGACAGGTAAG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="238267878" stop="238267921" display_start="238267878" display_stop="238267921" variantLength="44" positionVCF="238267877" referenceAlleleVCF="ATTTCTCCTACTTCGCCCTAAGAGGGAATAAGGCGGACAGGTAAG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.238267879_238267922del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.238267879_238267922del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.237359236_237359279del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.237359236_237359279del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008676.1" sequenceAccession="NG_008676" sequenceVersion="1" change="g.59930_59973del">
            <Expression>NG_008676.1:g.59930_59973del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_057166.5" sequenceAccession="NM_057166" sequenceVersion="5" change="c.4489-28_4504del">
            <Expression>NM_057166.5:c.4489-28_4504del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_057167.4" sequenceAccession="NM_057167" sequenceVersion="4" change="c.5692-28_5707del">
            <Expression>NM_057167.4:c.5692-28_5707del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004369.4" sequenceAccession="NM_004369" sequenceVersion="4" change="c.6310-28_6325del" MANESelect="true">
            <Expression>NM_004369.4:c.6310-28_6325del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_473" sequenceAccession="LRG_473">
            <Expression>LRG_473:g.59930_59973del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004369.3" sequenceAccession="NM_004369" sequenceVersion="3" change="c.6310-28_6325delCTTACCTGTCCGCCTTATTCCCTCTTAGGGCGAAGTAGGAGAAA">
            <Expression>NM_004369.3:c.6310-28_6325delCTTACCTGTCCGCCTTATTCCCTCTTAGGGCGAAGTAGGAGAAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658796208" DB="ClinGen" />
        <XRef Type="rs" ID="1553553267" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004369.4(COL6A3):c.6310-28_6325del AND not provided" Accession="RCV000596147" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-11-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004369.4(COL6A3):c.6310-28_6325del AND Bethlem myopathy 1A" Accession="RCV000810824" Version="7">
        <ClassifiedConditionList TraitSetID="5661">
          <ClassifiedCondition DB="MedGen" ID="CN029274">Bethlem myopathy 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-08-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15563506</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18366090</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20976770</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=COL6A3</URL>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5661" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myopathy, benign congenital, with contractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bethlem myopathy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bethlem myopathy 1A</ElementValue>
                <XRef ID="MONDO:0024530" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1A</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="610" DB="Orphanet" />
              <XRef ID="CN029274" DB="MedGen" />
              <XRef ID="MONDO:0024530" DB="MONDO" />
              <XRef Type="MIM" ID="158810" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1376558" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="57310_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000704159" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000704158" DateChanged="2019-08-06" Version="1">
            <Comment Type="MergeComment">SCV000704158 was merged into SCV000704159 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2016-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL6A3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="-" referenceAllele="TTTCTCCTACTTCGCCCTAAGAGGGAATAAGGCGGACAGGTAAG" start="238267878" stop="238267921" variantLength="44" />
            <GeneLocation>NM_004369.3:IVS18</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=COL6A3</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1845166" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4998590|MedGen:CN029274" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000951060" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20976770</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20976770</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15563506</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18366090</ID>
          </Citation>
          <Comment>This variant is not present in population databases (ExAC no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Loss-of-function variants in COL6A3 are known to cause autosomal recessive COL6A3-related disorders (PMID: 20976770). However, variants that disrupt splice sites in¬†COL6A3¬†have also been reported to cause autosomal dominant COL6A3-related disorders (PMID: 20976770, 15563506, 18366090). This variant has not been reported in the literature in individuals with COL6A3-related disease. This variant is a deletion of the genomic region encompassing part of exon 19 (c.6310-28_6325del) of the COL6A3 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL6A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.238267878_238267921del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN029274" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1845166" TraitType="Disease" MappingType="XRef" MappingValue="CN029274" MappingRef="MedGen">
        <MedGen CUI="CN029274" Name="Bethlem myopathy 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1376558" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

